Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.37 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.36 |
| ▸ | BCL2 | P10415 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | PTGIR | P43119 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3163844 | 0.89 | MLYCD (0.44) | MLYCDTDP1L3MBTL1MAPTMEN1 | |
| SCHEMBL29000233 | 0.86 | ACHE (0.47) | TDP1MCL1ACHECYP2C9CYP2C19 | |
| SCHEMBL3281147 | 0.86 | MLYCD (0.48) | MLYCDTDP1L3MBTL1MAPTMEN1 | |
| SCHEMBL203945 | 0.86 | ACHE (0.47) | TDP1MCL1ACHECYP2C9CYP2C19 | |
| Water SCHEMBL27795471 | 0.81 | TDP1 (0.53) | MLYCDTDP1L3MBTL1MAPTMEN1 | |
| SCHEMBL28107025 | 0.80 | MAOA (0.48) | L3MBTL1MAPTMCL1BCL2KDM4E | |
| SCHEMBL27872617 | 0.79 | ACHE (0.40) | TDP1MCL1ACHECYP2C9CYP2C19 | |
| SCHEMBL12245875 | 0.78 | ACHE (0.57) | MLYCDTDP1L3MBTL1MAPTMEN1 | |
| SCHEMBL83853 | 0.78 | ACHE (0.57) | MLYCDTDP1L3MBTL1MAPTMEN1 | |
| SCHEMBL11121834 | 0.78 | ACHE (0.57) | MLYCDTDP1L3MBTL1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102311678-B | Active energy ray-curable ink-jet ink compositions | 东洋油墨SC控股株式会社 | 2016-09-14 | — | — | CN | disclosed |
| CN-103517953-B | Photopolymerizable inkjet ink, ink cartridge, and inkjet recording apparatus | RICOH CO.,LTD. (JP) | 2015-12-23 | — | — | CN | disclosed |
| US-9034236-B2 | Substrate-based additive fabrication process | DSM IP ASSETS B.V. (NL) | 2015-05-19 | — | — | US | disclosed |
| EP-2513722-A1 | LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION | DSM IP Assets B.V. (NL) | 2012-10-24 | — | — | EP | disclosed |
| US-20120259031-A1 | LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION | DSM IP ASSETS, B.V. (NL) | 2012-10-11 | — | — | US | disclosed |
| US-20120251829-A1 | SUBSTRATE-BASED ADDITIVE FABRICATION PROCESS | DSM IP ASSETS, B.V. (NL) | 2012-10-04 | — | — | US | disclosed |
| US-20120251841-A1 | LIQUID RADIATION CURABLE RESINS FOR ADDITIVE FABRICATION COMPRISING A TRIARYL SULFONIUM BORATE CATIONIC PHOTOINITIATOR | DSM IP ASSETS, B.V. (NL) | 2012-10-04 | — | — | US | disclosed |
| EP-2396299-A1 | LIQUID RADIATION CURABLE RESINS FOR ADDITIVE FABRICATION COMPRISING A TRIARYL SULFONIUM BORATE CATIONIC PHOTOINITIATOR | DSM IP Assets B.V. (NL) | 2011-12-21 | — | — | EP | disclosed |
| WO-2011075555-A1 | LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION | DSM IP ASSETS, B.V. (NL) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011075553-A1 | LIQUID RADIATION CURABLE RESINS FOR ADDITIVE FABRICATION COMPRISING A TRIARYL SULFONIUM BORATE CATIONIC PHOTOINITIATOR | DSM IP ASSETS, B.V. (NL) | 2011-06-23 | — | — | WO | disclosed |
| CN-1476449-A | Halogenated optical polymer composition | ��Ļ���Ű˾ | 2004-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120251841-A1 | LIQUID RADIATION CURABLE RESINS FOR ADDITIVE FABRICATION COMPRISING A TRIARYL SULFONIUM BORATE CATIONIC PHOTOINITIATOR | TERB1, ATR, LRRFIP1 | MLYCD 4800/4885TDP1 575/4885L3MBTL1 177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.